https://www.pharmaradar360.com/article/ukhsa-updates-heat-health-alerts-across-england-ed2386aedcea3cbcPharma Surgeen2026-08-02T14:44:11.000ZUKHSA updates heat health alerts across Englandhttps://www.pharmaradar360.com/article/this-mad-scientist-built-india-s-first-pharmaceutical-company-made-major-discove-cc17bd33ba1c5925Pharma Surgeen2026-08-02T14:02:13.000ZTHIS ‘mad scientist’ built India’s first pharmaceutical company, made major discoveries in Chemistry, donated entire fortune to charity, his name was…https://www.pharmaradar360.com/article/study-hiv-injectable-drug-offers-pregnant-lactating-mothers-100-protection-fd8a9e947cd3f2f2Pharma Surgeen2026-08-02T13:00:59.000ZSTUDY: HIV injectable drug offers pregnant, lactating mothers 100% protectionhttps://www.pharmaradar360.com/article/union-minister-rajiv-ranjan-singh-stresses-research-in-pharma-and-biotech-sector-6900c5ef1cdf19fcPharma Surgeen2026-08-02T12:57:41.000ZUnion Minister Rajiv Ranjan Singh stresses research in pharma and biotech sectors | Akashvani Newshttps://www.pharmaradar360.com/article/senate-panel-will-examine-biotech-s-role-in-u-s-health-resilience-b12f7b7387463c14Pharma Surgeen2026-08-02T12:28:52.000ZSenate Panel Will Examine Biotech's Role in U.S. Health Resiliencehttps://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-zhejiang-shouxiangu-pharmaceutical-holding-c-656387bdd0f2cc33Pharma Surgeen2026-08-02T11:55:25.000ZEnterprise value to EBIT forward of Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A – SSE:603896https://www.pharmaradar360.com/article/5-biotech-stocks-that-delivered-big-gains-key-catalysts-ahead-for-qure-cdna-adpt-09bb6aed56c386c1Pharma Surgeen2026-08-02T10:54:00.000Z5 Biotech Stocks That Delivered Big Gains - Key Catalysts Ahead For QURE, CDNA, ADPT, ELVN & AMLXhttps://www.pharmaradar360.com/article/hoth-s-pivot-from-biotech-to-space-tech-sparks-massive-rally-in-stock-retail-und-fea1a8d486dec34bPharma Surgeen2026-08-02T10:48:49.000ZHOTH’s Pivot From Biotech To Space Tech Sparks Massive Rally In Stock – Retail Underlines Importance Of Securing Fresh Dealshttps://www.pharmaradar360.com/article/kelun-pharmaceutical-002422-sz-multiple-drug-products-provisionally-awarded-in-t-ec5ed1e2d068e3bdPharma Surgeen2026-08-02T10:23:12.000ZKelun Pharmaceutical (002422.SZ): Multiple drug products provisionally awarded in the 12th batch of national centralized drug procurementhttps://www.pharmaradar360.com/article/my-job-is-to-ensure-safe-food-fda-chief-warns-of-wider-crackdown-after-restauran-84c9f26061c96b9ePharma Surgeen2026-08-02T09:47:37.000Z'My job is to ensure safe food': FDA chief warns of wider crackdown after restaurant hygiene inspectionshttps://www.pharmaradar360.com/article/etfs-investing-in-zhejiang-starry-pharmaceutical-co-ltd-class-a-stocks-6efc76bc1b8fbb75Pharma Surgeen2026-08-02T09:24:49.000ZETFs Investing in Zhejiang Starry Pharmaceutical Co., Ltd. Class A Stockshttps://www.pharmaradar360.com/article/a-who-was-taking-a-treatment-for-dyslipidemia-lipidemia-recently-saw-that-the-na-4d8db33b79dcc375Pharma Surgeen2026-08-02T08:47:41.000ZA, who was taking a treatment for dyslipidemia (lipidemia), recently saw that the name of the drug c..https://www.pharmaradar360.com/article/the-pharmaceutical-industry-is-expanding-retro-marketing-with-the-history-of-lon-72ff8e3f7ad82859Pharma Surgeen2026-08-02T08:44:50.000ZThe pharmaceutical industry is expanding "retro marketing" with the history of long-lived brands and..https://www.pharmaradar360.com/article/maharashtra-fda-chief-vows-stricter-action-against-hygiene-medicine-norm-violati-a604a85fa4139346Pharma Surgeen2026-08-02T08:39:16.000ZMaharashtra FDA chief vows stricter action against hygiene, medicine norm violationshttps://www.pharmaradar360.com/article/amgen-amgn-partners-with-mrbeast-to-fund-pediatric-cancer-research-and-reach-500-2d74ff7aa3cf822fPharma Surgeen2026-08-02T08:15:46.000ZAmgen (AMGN) Partners With MrBeast To Fund Pediatric Cancer Research And Reach 500 Million Subscribershttps://www.pharmaradar360.com/article/why-is-maharashtra-fda-targeting-restaurants-commissioner-tukaram-mundhe-explain-66ab71c1d13f28d3Pharma Surgeen2026-08-02T08:10:21.000ZWhy Is Maharashtra FDA Targeting Restaurants? Commissioner Tukaram Mundhe Explainshttps://www.pharmaradar360.com/article/ppb-chair-munyu-calls-for-ethical-practice-as-kenya-advances-pharmaceutical-refo-d114ff4715d387a6Pharma Surgeen2026-08-02T07:53:00.000ZPPB chair Munyu calls for ethical practice as Kenya advances pharmaceutical reformshttps://www.pharmaradar360.com/article/dr-reddy-s-gets-usfda-nod-for-rituximab-biosimilar-89b7034eadc010f7Pharma Surgeen2026-08-02T07:34:35.000ZDr. Reddy's Gets USFDA Nod for Rituximab Biosimilarhttps://www.pharmaradar360.com/article/the-clinical-trial-that-asks-whether-your-current-treatment-should-exist-32b3fdfc0f99c6daPharma Surgeen2026-08-02T07:28:08.000ZThe Clinical Trial That Asks Whether Your Current Treatment Should Existhttps://www.pharmaradar360.com/article/ntla-stock-surges-35-overnight-retail-mood-peaks-ahead-of-first-ever-phase-3-rea-d5beb93535a18e5ePharma Surgeen2026-08-02T07:21:30.000ZNTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapyhttps://www.pharmaradar360.com/article/sls-stock-hits-over-3-year-high-as-aml-drug-trial-nears-final-readout-wall-stree-d690b1c596b74875Pharma Surgeen2026-08-02T07:07:40.000ZSLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upsidehttps://www.pharmaradar360.com/article/gas-crisis-strikes-paracetamol-api-other-industries-03fc12f35536dfe1Pharma Surgeen2026-08-02T06:04:23.000ZGas crisis strikes paracetamol API, other industrieshttps://www.pharmaradar360.com/article/case-biotech-research-sowing-seeds-for-jamaica-s-future-660a5137ad7be6a5Pharma Surgeen2026-08-02T06:04:11.000ZCASE biotech research sowing seeds for Jamaica’s futurehttps://www.pharmaradar360.com/article/price-to-sales-forward-of-protect-pharmaceutical-corp-otc-prtt-def4c2ab610055fdPharma Surgeen2026-08-02T05:51:54.000ZPrice to sales forward of Protect Pharmaceutical Corp – OTC:PRTThttps://www.pharmaradar360.com/article/concord-biotech-q1-fy27-strong-growth-marred-by-sequential-decline-and-valuation-9acf88826b7b7460Pharma Surgeen2026-08-02T05:31:26.000ZConcord Biotech Q1 FY27: Strong Growth Marred by Sequential Decline and Valuation Concernshttps://www.pharmaradar360.com/article/matica-bio-zeroes-in-on-bridging-global-biotech-with-korea-795be978ba0a6b14Pharma Surgeen2026-08-02T05:21:08.000ZMatica Bio zeroes in on bridging global biotech with Koreahttps://www.pharmaradar360.com/article/tukaram-mundhe-explains-his-philosophy-as-fda-cracks-down-on-restaurants-my-role-e59e262a9ece9234Pharma Surgeen2026-08-02T05:17:46.000ZTukaram Mundhe Explains His Philosophy As FDA Cracks Down On Restaurants: 'My Role Is To...'https://www.pharmaradar360.com/article/medicamen-biotech-ltd-is-rated-sell-f7b5b6fe4af16e07Pharma Surgeen2026-08-02T05:05:44.000ZMedicamen Biotech Ltd is Rated Sellhttps://www.pharmaradar360.com/article/cramer-this-biotech-stock-could-be-worth-over-100-billion-on-an-fda-approval-bra-124a3cc586a9fa9ePharma Surgeen2026-08-02T05:00:37.000ZCramer: This Biotech Stock Could Be Worth Over $100 Billion On An FDA Approval Braves Standings (7nBNgCwFes)https://www.pharmaradar360.com/article/kathua-biotech-park-to-drive-innovation-jobs-across-j-k-north-india-jitendra-sin-21fcb876fbc77ec6Pharma Surgeen2026-08-02T04:17:16.000ZKathua Biotech Park to drive innovation, jobs across J&K, north India: Jitendra Singhhttps://www.pharmaradar360.com/article/govt-committed-to-building-globally-competitive-innovation-driven-pharma-sector-7ea9ff6bb1f753d6Pharma Surgeen2026-08-02T03:28:00.000ZGovt committed to building globally competitive, innovation-driven pharma sector: Piyush Goyalhttps://www.pharmaradar360.com/article/piyush-goyal-invites-global-pharma-firms-to-invest-in-india-b5bf561e4e00c67aPharma Surgeen2026-08-02T03:27:53.000ZPiyush Goyal invites global pharma firms to invest in Indiahttps://www.pharmaradar360.com/article/biotech-pro-testosterone-booster-reviews-real-user-insights-for-long-term-metabo-47fba996b9018eb6Pharma Surgeen2026-08-02T03:26:54.000ZBiotech Pro Testosterone Booster Reviews: Real User Insights for Long-Term Metabolic Health *arBxoRmlL*https://www.pharmaradar360.com/article/what-is-the-latest-treatment-for-erectile-dysfunction-2023-view-9zawavrxl-61c8f12446c27241Pharma Surgeen2026-08-02T03:02:30.000Zwhat is the latest treatment for erectile dysfunction 2023 - View 9zawaVRXlhttps://www.pharmaradar360.com/article/mounjaro-fda-approval-status-2026-clinical-weight-loss-data-and-doctor-recommend-e05d64b9262d491ePharma Surgeen2026-08-02T02:19:55.000ZMounjaro Fda Approval Status 2026: Clinical Weight Loss Data And Doctor Recommendations [ZkkgCv7lTTq]https://www.pharmaradar360.com/article/michael-explains-exciting-apitegromab-clinical-trial-ufo-files-j8htefim7t-a4b77ac71e3c8ab0Pharma Surgeen2026-08-02T02:12:16.000ZMichael Explains Exciting Apitegromab Clinical Trial Ufo Files (j8HtefIM7t)https://www.pharmaradar360.com/article/etfs-investing-in-samsung-pharmaceutical-co-ltd-stocks-6b3fe25790c69497Pharma Surgeen2026-08-02T01:51:33.000ZETFs Investing in SAMSUNG PHARMACEUTICAL.CO.,Ltd. Stockshttps://www.pharmaradar360.com/article/etfs-investing-in-xizang-weixinkang-pharmaceutical-co-ltd-class-a-stocks-dff793f4d1b9d951Pharma Surgeen2026-08-02T01:50:34.000ZETFs Investing in Xizang Weixinkang Pharmaceutical Co., Ltd. Class A Stockshttps://www.pharmaradar360.com/article/glp-1-obesity-drug-news-today-latest-advancements-and-clinical-breakthroughs-gw6-dc471a7fe6be6c3cPharma Surgeen2026-08-02T01:44:39.000ZGlp 1 Obesity Drug News Today: Latest Advancements And Clinical Breakthroughs [gw6cCHEEIHc]https://www.pharmaradar360.com/article/testrovax-testosterone-boosting-compound-90ct-by-novex-biotech-view-dwbsgefpa-6caaa358a8002823Pharma Surgeen2026-08-02T01:07:19.000Z# TestroVax Testosterone Boosting Compound 90ct by Novex Biotech - View dWBSGefPahttps://www.pharmaradar360.com/article/the-ultimate-guide-to-finding-the-cheapest-glp-1-without-insurance-costs-compoun-536d665e1e103b5dPharma Surgeen2026-08-02T00:53:59.000ZThe Ultimate Guide To Finding The Cheapest Glp 1 Without Insurance: Costs, Compounded Options, And Safety [MpalSXSTADx]https://www.pharmaradar360.com/article/court-rules-blocking-abortion-pill-site-justified-59667787ca317483Pharma Surgeen2026-08-02T00:53:38.000ZCourt Rules Blocking Abortion Pill Site Justifiedhttps://www.pharmaradar360.com/article/keto-blast-gummies-fda-what-the-regulations-really-mean-for-this-supplement-v3jg-f4f76269c4465f93Pharma Surgeen2026-08-02T00:49:31.000ZKeto Blast Gummies Fda: What The Regulations Really Mean For This Supplement [V3JGqoPlI6c]https://www.pharmaradar360.com/article/tension-has-been-running-high-in-the-global-pharmaceutical-industry-two-companie-d151e30148a1c80dPharma Surgeen2026-08-02T00:30:35.000ZTension has been running high in the global pharmaceutical industry. Two companies that dominate the..https://www.pharmaradar360.com/article/etfs-investing-in-nanjing-king-friend-biochemical-pharmaceutical-co-ltd-class-a-f38663ad4a773a64Pharma Surgeen2026-08-02T00:30:32.000ZETFs Investing in Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A Stockshttps://www.pharmaradar360.com/article/genbio-inc-to-participate-in-the-2026-asia-bio-partnering-forum-in-singapore-36ff03d0ccb520f5Pharma Surgeen2026-08-02T00:01:28.000ZGenBio Inc. to Participate in the 2026 Asia Bio Partnering Forum in Singaporehttps://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-34a00ada40e55abaPharma Surgeen2026-08-02T00:00:00.000Znatco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-82556f86373965b4Pharma Surgeen2026-08-02T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-olaparib-tablets-from-the-united-states-fo-23c0926c2cb59916Pharma Surgeen2026-08-02T00:00:00.000Znatco receives tentative approval for olaparib tablets from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-2219d060cc87639cPharma Surgeen2026-08-02T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-5ff3e7c250fcf4adPharma Surgeen2026-08-02T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/natco-pharma-limited-gets-approval-from-its-board-of-directors-for-increasing-it-e0f2076050d33d85Pharma Surgeen2026-08-02T00:00:00.000Znatco pharma limited gets approval from its board of directors for increasing its stake in adcock ingram holdings proprietary limited to 49https://www.pharmaradar360.com/article/natco-pharma-limited-completes-acquisition-of-additional-13-25-stake-in-adcock-i-694c363a3f391b01Pharma Surgeen2026-08-02T00:00:00.000Znatco pharma limited completes acquisition of additional 13 25 stake in adcock ingram holdings proprietary limitedhttps://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-4182a5a0bb2814b4Pharma Surgeen2026-08-02T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-2de08bbf931cc514Pharma Surgeen2026-08-02T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-85a475c39cb2f903Pharma Surgeen2026-08-02T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-d9ea824d3dd6cfb5Pharma Surgeen2026-08-02T00:00:00.000Znatco and lupin receive approval from u s fda for eribulin mesylate injectionhttps://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-711c0e8ceb6afe4ePharma Surgeen2026-08-02T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-b5d902a2dadbd887Pharma Surgeen2026-08-02T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/home-page-e493df6124da02e1Pharma Surgeen2026-08-02T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/work-related-quality-of-life-and-its-demographic-correlates-among-nurse-educator-345248ec12d07e41Pharma Surgeen2026-08-02T00:00:00.000ZWork-Related Quality of Life and Its Demographic Correlates among Nurse Educators and Clinical Instructors in Philippine Higher Education Institutions: A Descriptive-Correlational Studyhttps://www.pharmaradar360.com/article/the-relationship-between-legal-instructions-and-factual-circumstances-in-a-jury-eca40a6464a4bedfPharma Surgeen2026-08-02T00:00:00.000ZTHE RELATIONSHIP BETWEEN LEGAL INSTRUCTIONS AND FACTUAL CIRCUMSTANCES IN A JURY TRIALhttps://www.pharmaradar360.com/article/clinical-and-molecular-study-of-upper-respiratory-tract-infections-caused-by-kle-b31dec8fe4eadd6cPharma Surgeen2026-08-02T00:00:00.000ZCLINICAL AND MOLECULAR STUDY OF UPPER RESPIRATORY TRACT INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE IN CATShttps://www.pharmaradar360.com/article/the-effects-of-combined-periodontal-and-orthodontic-treatment-in-periodontally-c-8daaad2d4417293ePharma Surgeen2026-08-02T00:00:00.000ZThe Effects of Combined Periodontal and Orthodontic Treatment in Periodontally Compromised Adult Patients: A Longitudinal Clinical Studyhttps://www.pharmaradar360.com/article/clinical-approaches-to-non-ordinary-experiences-noes-scoping-review-and-bibliome-e7f1148c3a3e3cd9Pharma Surgeen2026-08-02T00:00:00.000ZClinical Approaches to Non-Ordinary Experiences (NOEs): scoping review and bibliometric analysishttps://www.pharmaradar360.com/article/perceptions-and-practices-of-medical-interns-on-clinical-empathy-3b2f16f191e564b6Pharma Surgeen2026-08-02T00:00:00.000ZPerceptions and Practices of Medical Interns on Clinical Empathyhttps://www.pharmaradar360.com/article/association-of-the-lt-i-gt-t-53-pro72arg-lt-i-gt-polymorphism-with-lymphovascula-59bc4cd9c81c6fa1Pharma Surgeen2026-08-02T00:00:00.000ZAssociation of the <i>TР53 Pro72Arg</i> polymorphism with lymphovascular space invasion and survival in cervical cancerhttps://www.pharmaradar360.com/article/improvement-in-lipid-profile-and-sex-hormones-with-oleoylethanolamide-supplement-cb68a165324e2dabPharma Surgeen2026-08-02T00:00:00.000ZImprovement in Lipid Profile and Sex Hormones with Oleoylethanolamide Supplement in Women with Polycystic Ovary Syndrome: A Clinical Trialhttps://www.pharmaradar360.com/article/the-effect-of-moderate-intensity-crossfit-training-on-serum-vitamin-d-levels-and-1f851af11331ecccPharma Surgeen2026-08-02T00:00:00.000ZThe Effect of Moderate Intensity CrossFit Training on Serum Vitamin D Levels and Anthropometric Measures in Overweight/Obese Adult Women: A Randomized Controlled Trialhttps://www.pharmaradar360.com/article/knowledge-awareness-and-attitudes-toward-food-drug-interactions-among-a-sample-o-ae8cd282adeaa6b1Pharma Surgeen2026-08-02T00:00:00.000ZKnowledge, Awareness, and Attitudes toward Food–Drug Interactions among a Sample of the Iraqi Population in Baghdad: A Cross-Sectional Studyhttps://www.pharmaradar360.com/article/proximal-type-epithelioid-sarcoma-of-the-vulva-a-case-report-422a2b63e39e609aPharma Surgeen2026-08-02T00:00:00.000ZProximal Type” Epithelioid Sarcoma of the Vulva: A Case Reporthttps://www.pharmaradar360.com/article/functional-urinary-retention-in-children-and-adolescents-acase-report-fd1274ff3667ee9aPharma Surgeen2026-08-02T00:00:00.000ZFunctional Urinary Retention in Children and Adolescents: ACase Reporthttps://www.pharmaradar360.com/article/cholangiocellular-cancer-metastasis-in-the-terminal-ileum-a-case-report-ac0f63a6ac0d1d0dPharma Surgeen2026-08-02T00:00:00.000ZCholangiocellular Cancer Metastasis in the Terminal Ileum: A Case Reporthttps://www.pharmaradar360.com/article/management-of-daunorubicin-extravasation-with-dexrazoxane-in-a-child-47e75ebad289851cPharma Surgeen2026-08-02T00:00:00.000ZManagement of Daunorubicin Extravasation with Dexrazoxane in a Childhttps://www.pharmaradar360.com/article/a-confluence-of-autoimmunity-in-a-male-patient-severe-hypothyroidism-with-massiv-6caab5382092402dPharma Surgeen2026-08-02T00:00:00.000ZA Confluence of Autoimmunity in a Male Patient: Severe Hypothyroidism with Massive Pericardial Effusion, Sjögren’s Syndrome, and Vasculitishttps://www.pharmaradar360.com/article/extra-articular-tibia-vara-deformity-managed-with-kinematic-aligned-total-knee-a-3494ac0f325c97f0Pharma Surgeen2026-08-02T00:00:00.000ZExtra-Articular Tibia Vara Deformity Managed with Kinematic Aligned Total Knee Arthroplasty: A Case Reporthttps://www.pharmaradar360.com/article/percutaneous-endovascular-retrieval-of-an-embolized-chemotherapy-port-a-cath-fra-7e49f83d8e8fe113Pharma Surgeen2026-08-02T00:00:00.000ZPercutaneous Endovascular Retrieval of an Embolized Chemotherapy Port-A-Cath Fragment from the Superior Vena Cava Utilizing a Snare System: A Case Reporthttps://www.pharmaradar360.com/article/post-covid-19-complications-a-trigger-for-the-onset-of-depression-to-treatment-r-e1b2d5d93ef23e35Pharma Surgeen2026-08-02T00:00:00.000ZPost-COVID-19 Complications:A Trigger for the Onset of Depression to Treatment-Resistant Depression: A Case Reporthttps://www.pharmaradar360.com/article/clinical-utility-of-the-tamil-speech-in-noise-test-for-detecting-hidden-hearing-479bc4490a28fa58Pharma Surgeen2026-08-02T00:00:00.000ZClinical Utility of the Tamil Speech-in-Noise Test for Detecting Hidden Hearing Loss in Tinnitus with Normal Audiograms: Insights from Behavioral and Electrophysiological Measureshttps://www.pharmaradar360.com/article/mental-health-nursing-and-clinical-supervision-a-critical-discussion-of-key-issu-ce371292ac68e058Pharma Surgeen2026-08-02T00:00:00.000ZMental health nursing and clinical supervision: a critical discussion of key issues around international policy developmentshttps://www.pharmaradar360.com/article/the-first-72-hours-of-acute-pancreatitis-patterns-of-variability-in-early-clinic-a8efcb8d98e10620Pharma Surgeen2026-08-02T00:00:00.000ZThe first 72 hours of acute pancreatitis: patterns of variability in early clinical decision-makinghttps://www.pharmaradar360.com/article/clinical-determinants-of-neonatal-mortality-at-a-tertiary-hospital-in-a-resource-63eb86811fc72bf0Pharma Surgeen2026-08-02T00:00:00.000ZClinical determinants of neonatal mortality at a tertiary hospital in a resource limited setting: a retrospective cohort studyhttps://www.pharmaradar360.com/article/comparison-of-clinical-characteristics-and-outcomes-of-systemic-lupus-erythemato-431964f9d63c9d49Pharma Surgeen2026-08-02T00:00:00.000ZComparison of Clinical Characteristics and Outcomes of Systemic Lupus Erythematosus-associated Thrombotic Thrombocytopenic Purpura and Idiopathic Thrombotic Thrombocytopenic Purpura: A Single Centre Study from Eastern Indiahttps://www.pharmaradar360.com/article/workplace-violence-in-indonesian-clinical-learning-environments-cultural-and-org-c3e8849246cb6696Pharma Surgeen2026-08-02T00:00:00.000ZWorkplace Violence in Indonesian Clinical Learning Environments: Cultural and Organisational Contexts Shaping Nursing Students' Experienceshttps://www.pharmaradar360.com/article/in-vitro-antiamoebic-activity-of-novel-metronidazole-derivatives-and-silver-nano-09045b171394c5b0Pharma Surgeen2026-08-02T00:00:00.000ZIn vitro antiamoebic activity of novel metronidazole derivatives and silver nanoparticle formulations against clinical isolates of Entamoeba histolyticahttps://www.pharmaradar360.com/article/clinical-and-functional-outcomes-of-bone-defect-reconstruction-using-the-masquel-ba7c88c79a63570aPharma Surgeen2026-08-02T00:00:00.000ZClinical and Functional Outcomes of Bone Defect Reconstruction Using the Masquelet Technique: Experience with Rare Talus and Metatarsal Caseshttps://www.pharmaradar360.com/article/liposomal-bupivacaine-incisional-infiltration-for-postoperative-analgesia-after-f2d1db30bb27f94fPharma Surgeen2026-08-02T00:00:00.000ZLiposomal Bupivacaine Incisional Infiltration for Postoperative Analgesia After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Randomized Placebo-Controlled Trialhttps://www.pharmaradar360.com/article/a-radiotherapy-related-fibrosis-gene-signature-based-risk-model-for-predicting-p-b237f07fd4a9ac55Pharma Surgeen2026-08-02T00:00:00.000ZA radiotherapy-related fibrosis gene signature-based risk model for predicting prognosis and immunological features in lung adenocarcinomahttps://www.pharmaradar360.com/article/additional-effects-of-group-training-and-online-exercise-to-a-12-week-online-pac-d5c897d5f6908f3bPharma Surgeen2026-08-02T00:00:00.000ZAdditional effects of group training and online exercise to a 12-week online pacing and education module on health-related quality of life in adult patients with post COVID-19: a randomized controlled trialhttps://www.pharmaradar360.com/article/ai-automation-of-statistical-analysis-plans-in-clinical-trials-7ed23ec41ca67d2aPharma Surgeen2026-08-02T00:00:00.000ZAI Automation of Statistical Analysis Plans in Clinical Trialshttps://www.pharmaradar360.com/article/improving-hospital-process-management-through-process-mining-a-case-study-on-cov-7f4c3050870dc43fPharma Surgeen2026-08-02T00:00:00.000ZImproving Hospital Process Management Through Process Mining: A Case Study on COVID-19 Clinical Pathwayshttps://www.pharmaradar360.com/article/pills-and-perspectives-decoding-stance-on-drug-use-with-the-rxtance-dataset-07e6f2a2ecd03424Pharma Surgeen2026-08-02T00:00:00.000ZPills and Perspectives: Decoding Stance on Drug Use with the Rxtance Datasethttps://www.pharmaradar360.com/article/clinical-impact-of-gleason-pattern-5-on-doublet-versus-triplet-therapy-in-metast-5dca45945af00d31Pharma Surgeen2026-08-02T00:00:00.000ZClinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone‐Sensitive Prostate Cancerhttps://www.pharmaradar360.com/article/price-to-earnings-forward-of-jinghua-pharmaceutical-group-co-ltd-class-a-szse-00-11779d5399f32e7ePharma Surgeen2026-08-01T23:25:40.000ZPrice to earnings forward of Jinghua Pharmaceutical Group Co., Ltd. Class A – SZSE:002349https://www.pharmaradar360.com/article/fss-moves-to-end-inflated-biotech-tech-transfer-disclosures-a9c7730a8f13cc31Pharma Surgeen2026-08-01T23:09:00.000ZFSS moves to end inflated biotech tech-transfer disclosureshttps://www.pharmaradar360.com/article/north-indias-first-biotech-park-at-kathua-to-emerge-as-hub-of-innovation-agri-en-511161ca5f372c15Pharma Surgeen2026-08-01T22:55:52.000ZNorth Indias first Biotech Park at Kathua to emerge as hub of innovation, agri entrepreneurs: Dr Jitendrahttps://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-usd-revenue-breakdown-aquisuk-rtwl-b99b7bf4a9d4b8b0Pharma Surgeen2026-08-01T22:37:57.000ZRTW Biotech Opportunities Ltd USD Revenue Breakdown – AQUISUK:RTWLhttps://www.pharmaradar360.com/article/fda-approval-of-glp-1-medications-the-ultimate-guide-to-regulatory-milestones-an-97b5842cf540a4d3Pharma Surgeen2026-08-01T22:20:22.000ZFda Approval Of Glp 1 Medications: The Ultimate Guide To Regulatory Milestones And Clinical Impact [VZWtPYB6BTg]https://www.pharmaradar360.com/article/does-kb801-s-single-patient-signal-and-s-p-400-move-change-the-bull-case-for-kry-204005f49fe08ae1Pharma Surgeen2026-08-01T22:20:19.000ZDoes KB801’s Single-Patient Signal And S&P 400 Move Change The Bull Case For Krystal Biotech (KRYS)?https://www.pharmaradar360.com/article/xlv-vs-ibbq-is-broad-healthcare-exposure-or-biotech-growth-the-better-etf-buy-7bbbc1ec110c31e5Pharma Surgeen2026-08-01T22:11:00.000ZXLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?https://www.pharmaradar360.com/article/ono-pharmaceutical-tse-4528-stock-holds-appeal-despite-revenue-retreat-61102a46a4e27a40Pharma Surgeen2026-08-01T21:43:01.000ZOno Pharmaceutical (TSE:4528) Stock Holds Appeal Despite Revenue Retreathttps://www.pharmaradar360.com/article/etfs-investing-in-xiangxue-pharmaceutical-co-ltd-class-a-stocks-c301cd62fdc6835cPharma Surgeen2026-08-01T21:08:25.000ZETFs Investing in Xiangxue Pharmaceutical Co., Ltd. Class A Stockshttps://www.pharmaradar360.com/article/novo-nordisk-s-failed-heart-drug-trial-wipes-out-20-5-billion-in-market-value-f7f3079cc7639afdPharma Surgeen2026-08-01T20:31:59.000ZNovo Nordisk's Failed Heart Drug Trial Wipes Out $20.5 Billion in Market Valuehttps://www.pharmaradar360.com/article/pangen-biotech-inc-revenue-breakdown-krx-222110-4200ca6c479aa324Pharma Surgeen2026-08-01T20:29:43.000ZPanGen Biotech, Inc. Revenue Breakdown – KRX:222110https://www.pharmaradar360.com/article/legend-biotech-ceo-resigns-merck-deletes-trial-hint-and-fda-clears-novel-adhd-dr-83d92e05b6fe0b64Pharma Surgeen2026-08-01T20:19:42.000ZLegend Biotech CEO Resigns, Merck Deletes Trial Hint, And FDA Clears Novel ADHD Drughttps://www.pharmaradar360.com/article/kathua-biotech-park-to-drive-innovation-jobs-across-north-india-jitendra-singh-daf73a8438d16eb9Pharma Surgeen2026-08-01T19:55:49.000ZKathua Biotech Park to drive innovation, jobs across North India: Jitendra Singhhttps://www.pharmaradar360.com/article/trump-proposes-generic-drug-tariffs-effective-2028-signaling-fresh-push-to-resho-ea27d5bfc519669aPharma Surgeen2026-08-01T19:51:46.000ZTrump Proposes Generic Drug Tariffs Effective 2028, Signaling Fresh Push to Reshore Pharmaceutical Production - GAAP Earnings Reporthttps://www.pharmaradar360.com/article/ember-lifesciences-and-alfresa-corp-to-improve-quality-of-pharmaceutical-cold-ch-daf585b07e5c70f7Pharma Surgeen2026-08-01T19:38:48.000ZEmber LifeSciences and Alfresa Corp to improve quality of pharmaceutical cold chain in Japanhttps://www.pharmaradar360.com/article/xlv-vs-pbe-is-a-low-cost-healthcare-etf-the-better-buy-than-a-focused-biotech-sp-6e26dc6291560cbbPharma Surgeen2026-08-01T18:57:00.000ZXLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?https://www.pharmaradar360.com/article/pharmaceutical-pollution-needs-to-be-stopped-f91a3b0deecd6da7Pharma Surgeen2026-08-01T18:43:57.000ZPharmaceutical pollution needs to be stoppedhttps://www.pharmaradar360.com/article/xlv-vs-pbe-healthcare-sector-stability-vs-biotech-growth-ad6d67439c85ea21Pharma Surgeen2026-08-01T18:38:00.000ZXLV vs PBE: Healthcare Sector Stability vs Biotech Growthhttps://www.pharmaradar360.com/article/anlon-healthcare-achieves-triple-digit-growth-in-q1-fy27-strengthens-integrated-ce8a7c8848b958c2Pharma Surgeen2026-08-01T18:27:00.000ZAnlon Healthcare Achieves Triple-Digit Growth in Q1 FY27, Strengthens Integrated Pharma Platformhttps://www.pharmaradar360.com/article/collegium-pharmaceutical-pain-cash-flows-are-funding-an-adhd-re-rating-nasdaq-co-9abc90c272f7f50ePharma Surgeen2026-08-01T18:12:27.000ZCollegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating (NASDAQ:COLL)https://www.pharmaradar360.com/article/iba-beximco-launch-first-executive-prog-for-pharma-professionals-1b04577955976ad8Pharma Surgeen2026-08-01T18:00:00.000ZIBA, Beximco launch first executive prog for pharma professionalshttps://www.pharmaradar360.com/article/6-reasons-pharma-manufacturing-has-eyes-on-puerto-rico-1eb4117c56b21852Pharma Surgeen2026-08-01T16:58:29.000Z6 Reasons Pharma Manufacturing Has Eyes On Puerto Ricohttps://www.pharmaradar360.com/article/mou-signed-to-operationalise-north-india-s-first-industrial-biotech-park-in-kath-80282e81f07c899cPharma Surgeen2026-08-01T16:28:12.000ZMoU Signed to Operationalise North India’s First Industrial Biotech Park in Kathua; Dr Jitendra Singh Calls it a Major Boost for J&K’s Biotechnology Ecosystemhttps://www.pharmaradar360.com/article/concord-biotech-q1-fy27-revenue-jumps-26-to-257-5-crore-cbc0c948de170e97Pharma Surgeen2026-08-01T16:04:09.000ZConcord Biotech: Q1 FY27 Revenue Jumps 26% to ₹257.5 Crorehttps://www.pharmaradar360.com/article/pharmaceutical-safety-review-2026-exposes-why-pills-to-lose-weight-rarely-delive-6e3a9fb0b26beef9Pharma Surgeen2026-08-01T15:25:22.000ZPharmaceutical Safety Review 2026 Exposes Why Pills To Lose Weight Rarely Deliver Lasting Results [SAwa8ztf72m]https://www.pharmaradar360.com/article/bharat-biotech-md-calls-on-students-to-contribute-meaningfully-to-society-7c6bca1c66a1e8bdPharma Surgeen2026-08-01T15:20:01.000ZBharat Biotech MD calls on students to contribute meaningfully to societyhttps://www.pharmaradar360.com/article/a-new-adhd-drug-just-got-fda-approval-here-s-what-makes-it-different-9564906794f54dfbPharma Surgeen2026-08-01T15:06:08.000ZA new ADHD drug just got FDA approval. Here's what makes it different.https://www.pharmaradar360.com/article/the-5-most-interesting-analyst-questions-from-west-pharmaceutical-services-s-q2-4e293d35c7adb921Pharma Surgeen2026-08-01T14:59:57.000ZThe 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Callhttps://www.pharmaradar360.com/article/pfizer-s-litfulo-clears-two-phase-3-vitiligo-trials-paving-way-for-global-regula-8b338a80a65702e1Pharma Surgeen2026-08-01T14:24:34.000ZPfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filingshttps://www.pharmaradar360.com/article/novo-nordisk-s-phase-3-zeus-trial-misses-cardiovascular-endpoint-for-ziltivekima-df5015a23170cf4bPharma Surgeen2026-08-01T14:24:34.000ZNovo Nordisk's Phase 3 ZEUS trial misses cardiovascular endpoint for Ziltivekimabhttps://www.pharmaradar360.com/article/how-should-clinicians-weigh-kidney-cancer-data-from-asco-2026-d78bb00c5277b027Pharma Surgeen2026-08-01T14:08:25.000ZHow Should Clinicians Weigh Kidney Cancer Data From ASCO 2026?https://www.pharmaradar360.com/article/north-china-pharmaceutical-company-ltd-class-a-revenue-breakdown-sse-600812-259d791f9fd24b04Pharma Surgeen2026-08-01T14:05:24.000ZNorth China Pharmaceutical Company Ltd. Class A Revenue Breakdown – SSE:600812https://www.pharmaradar360.com/article/redefining-hiv-management-emerging-antiretroviral-drug-classes-and-immunologic-s-f44fd6ab08b918ddPharma Surgeen2026-08-01T13:52:36.000ZRedefining HIV Management: Emerging Antiretroviral Drug Classes and Immunologic Strategies Shaping the Future of HIV Treatment, Preventionhttps://www.pharmaradar360.com/article/kathua-biotech-park-to-drive-innovation-jobs-in-j-k-north-india-3c6d734b433228a9Pharma Surgeen2026-08-01T13:50:51.000ZKathua Biotech Park to Drive Innovation & Jobs in J&K, North Indiahttps://www.pharmaradar360.com/article/concord-biotech-q1-results-net-profit-rises-31-yoy-to-57-7-crore-38d1c69e24514215Pharma Surgeen2026-08-01T13:35:39.000ZConcord Biotech Q1 Results: Net profit rises 31% YoY to ₹57.7 crorehttps://www.pharmaradar360.com/article/sichuan-kelun-biotech-biopharmaceutical-co-revenue-breakdown-otc-skbhf-958320008ec2c7baPharma Surgeen2026-08-01T13:25:29.000ZSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO Revenue Breakdown – OTC:SKBHFhttps://www.pharmaradar360.com/article/top-portage-biotech-alp-competitors-2026-f77a722fc11c05f7Pharma Surgeen2026-08-01T13:11:35.000ZTop Portage Biotech (ALP) Competitors 2026https://www.pharmaradar360.com/article/exposing-the-most-dangerous-celebrity-skincare-launches-food-ej86yvxapf-ccc67ff46c2ca9e6Pharma Surgeen2026-08-01T13:08:23.000ZExposing The Most Dangerous Celebrity Skincare Launches Food (ej86YVXAPF)https://www.pharmaradar360.com/article/nafdac-joins-the-federal-ministry-of-health-and-social-welfare-nutrition-partner-59bc7b4ca73e2c7cPharma Surgeen2026-08-01T13:01:42.000ZNAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026https://www.pharmaradar360.com/article/the-third-dimension-of-antibody-therapy-078bced9c76afc8fPharma Surgeen2026-08-01T12:56:15.000ZThe Third Dimension of Antibody Therapyhttps://www.pharmaradar360.com/article/novo-nordisk-s-failed-heart-drug-trial-deepens-a-season-of-setbacks-c2a03fcd726aeb14Pharma Surgeen2026-08-01T12:53:11.000ZNovo Nordisk's Failed Heart Drug Trial Deepens a Season of Setbackshttps://www.pharmaradar360.com/article/concord-biotech-shareholders-approve-enhanced-loan-limits-at-agm-0f4a96d68b9b8506Pharma Surgeen2026-08-01T12:29:06.000ZConcord Biotech shareholders approve enhanced loan limits at AGMhttps://www.pharmaradar360.com/article/biotech-international-limited-reports-strong-fy2025-performance-b7463891495dd9efPharma Surgeen2026-08-01T12:00:00.000ZBiotech International Limited Reports Strong FY2025 Performancehttps://www.pharmaradar360.com/article/yemeni-honey-from-natural-resource-to-promising-pillar-for-pharmaceutical-indust-456b8166cf6df91bPharma Surgeen2026-08-01T11:52:00.000ZYemeni Honey: From Natural Resource to Promising Pillar for Pharmaceutical Industryhttps://www.pharmaradar360.com/article/karnataka-to-ban-junk-food-around-schools-25ea1f750a5cc074Pharma Surgeen2026-08-01T11:49:14.000ZKarnataka to ban junk food around schoolshttps://www.pharmaradar360.com/article/north-indias-first-industrial-biotech-park-at-kathua-to-drive-j-ks-biotechnology-691061b42535b24bPharma Surgeen2026-08-01T11:41:25.000ZNorth Indias First Industrial Biotech Park At Kathua To Drive J&Ks Biotechnology Revolution: Dr Jitendrahttps://www.pharmaradar360.com/article/north-india-s-first-biotech-park-at-kathua-a-hub-of-biotech-driven-entrepreneurs-74a6132819f1e003Pharma Surgeen2026-08-01T11:27:46.000ZNorth India’s First Biotech Park At Kathua, A Hub Of Biotech Driven Entrepreneurship In The Region: Dr. Jitendrahttps://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-kolmar-biotech-inc-krx-215380-c5226d0b372e4e11Pharma Surgeen2026-08-01T11:23:37.000ZEnterprise value to EBIT forward of Kolmar BioTech. Inc. – KRX:215380https://www.pharmaradar360.com/article/sun-pharma-shareholders-approve-all-resolutions-at-34th-agm-fb24251913c71d1ePharma Surgeen2026-08-01T11:19:39.000ZSun Pharma shareholders approve all resolutions at 34th AGMhttps://www.pharmaradar360.com/article/drug-repurposing-s-next-challenge-turning-discoveries-into-treatments-5ee7a0a69bf33feaPharma Surgeen2026-08-01T10:50:10.000ZDrug Repurposing’s Next Challenge: Turning Discoveries Into Treatmentshttps://www.pharmaradar360.com/article/why-drug-safety-has-become-india-s-next-pharmaceutical-imperative-0220321938f75a9fPharma Surgeen2026-08-01T10:46:53.000ZWhy Drug Safety Has Become India's Next Pharmaceutical Imperativehttps://www.pharmaradar360.com/article/janus-henderson-group-plc-has-145-08-million-position-in-teva-pharmaceutical-ind-9265df161f0885d9Pharma Surgeen2026-08-01T10:32:33.000ZJanus Henderson Group PLC Has $145.08 Million Position in Teva Pharmaceutical Industries Ltd. $TEVAhttps://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-usd-revenue-breakdown-fwb-0bm-46c5c01c196fdc36Pharma Surgeen2026-08-01T10:18:15.000ZRTW Biotech Opportunities Ltd USD Revenue Breakdown – FWB:0BMhttps://www.pharmaradar360.com/article/over-1-500-experts-attended-the-hanoi-hospital-pharmaceutical-science-conference-f24c9beec4c56266Pharma Surgeen2026-08-01T10:14:49.000ZOver 1,500 experts attended the Hanoi Hospital Pharmaceutical Science Conference (expanded) in Nghe An.https://www.pharmaradar360.com/article/fluctuations-in-entrance-exam-scores-for-medical-and-pharmaceutical-schools-in-t-e6ac60587778fed9Pharma Surgeen2026-08-01T10:14:29.000ZFluctuations in entrance exam scores for medical and pharmaceutical schools in the North over the past 3 years, with "hot" majors exceeding 27 points.https://www.pharmaradar360.com/article/ebola-disease-caused-by-bundibugyo-virus-democratic-republic-of-the-congo-c7d412bd268a27acPharma Surgeen2026-08-01T10:13:28.000ZEbola disease caused by Bundibugyo virus - Democratic Republic of the Congohttps://www.pharmaradar360.com/article/krystal-biotech-inc-krys-valuation-pe-pb-fair-value-analysis-3b997157c5aec021Pharma Surgeen2026-08-01T09:37:27.000ZKrystal Biotech Inc (KRYS) Valuation: PE, PB & Fair Value Analysis